Your browser doesn't support javascript.
loading
Performance characteristics of INDICAID antigen rapid diagnostic test on SARS-CoV-2 samples during the omicron wave in Cameroon.
Fokam, Joseph; Takou, Désiré; Semengue, Ezechiel Ngoufack Jagni; Molimbou, Evariste; Chenwi Ambe, Collins; Durand Nka, Alex; Ndjeyep, Sandrine Djupsa; Beloumou, Grace Angong; Ka'e, Christelle Aude; Gouissi Anguechia, Davy-Hyacinthe; Mundo Nayang, Audrey Rachel; Moko Fotso, Larissa Gaëlle; Kengni Ngueko, Aurelie Minelle; Etame, Naomi-Karell; Tueguem, Pamela Patricia; Tommo Tchouaket, Carlos Michel; Fainguem, Nadine; Abega Abega, Cyrille; Abba, Aissatou; Tambe Ayuk Ngwese, Derrick; Djubgang Djoukwe, Rina; Akenji, Blaise; Okomo Assoumou, Marie-Claire; Mandeng, Nadia; Esso, Linda; Cappelli, Giulia; Shang, Judith; Ndongmo, Clement; Etoundi Mballa, Georges Alain; Ndembi, Nicaise; Colizzi, Vittorio; Perno, Carlo-Federico; Ndjolo, Alexis.
Afiliação
  • Fokam J; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Takou D; Faculty of Health Sciences, University of Buea, Buea, Cameroon.
  • Semengue ENJ; National Public Health Emergency Operations Coordination Centre, Ministry of Public Health, Yaoundé, Cameroon.
  • Molimbou E; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
  • Chenwi Ambe C; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Durand Nka A; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Ndjeyep SD; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Beloumou GA; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy.
  • Ka'e CA; Faculty of Science and Technology, Evangelic University of Cameroon, Bandjoun, Cameroon.
  • Gouissi Anguechia DH; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Mundo Nayang AR; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy.
  • Moko Fotso LG; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Kengni Ngueko AM; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Etame NK; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Tueguem PP; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Tommo Tchouaket CM; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy.
  • Fainguem N; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Abega Abega C; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
  • Abba A; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Tambe Ayuk Ngwese D; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Djubgang Djoukwe R; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
  • Akenji B; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Okomo Assoumou MC; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy.
  • Mandeng N; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Esso L; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
  • Cappelli G; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Shang J; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Ndongmo C; School of Health Sciences, Catholic University of Central Africa, Yaoundé, Cameroon.
  • Etoundi Mballa GA; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Ndembi N; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Colizzi V; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
  • Perno CF; Laboratory Department, Garoua Regional Health Centre, Garoua, Cameroon.
  • Ndjolo A; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.
Heliyon ; 10(9): e29937, 2024 May 15.
Article em En | MEDLINE | ID: mdl-38694118
ABSTRACT

Background:

WHO recommends the use of COVID-19 antigen rapid diagnostic tests (Ag-RDT) with at least 80 % sensitivity and 97 % specificity. In the era of Omicron variants, we sought to ascertain the performance of the INDICAID™ Ag-RDT compared to real-time PCR (RT-PCR) as the gold standard.

Methods:

A laboratory-based study was conducted among consenting individuals tested for COVID-19 at the virology laboratory of the Chantal BIYA International Reference Centre, Yaoundé-Cameron. The samples were processed by INDICAID™ Ag-RDT and DaAn Gene real-time PCR according to the manufacturer's instructions, and PCR-results were interpreted as per cycle thresholds (CT). The sensitivity, specificity, positive and negative predictive values (PPV and NVP) of INDICAID™ Ag-RDT were evaluated according to PCR CT-values.

Results:

A total of 565 nasopharyngeal swabs were collected from participants (median age [IQR] 40 [31-75]; M/F sex-ratio was 1.2 and 380 were vaccinated). Following PCR, overall COVID-19 positivity was 5.66 %. For CT < 37, INDICAID™ Ag-RDT sensitivity was 21.9 % (95%CI [8.3-39.9]), specificity 100 % (95%CI [99.3-100]); PPV 100 % (95%CI [59.0-100]), NPV 95.5 % (95%CI [93.4-97.1]) and kappa = 0.34 (95%CI [0.19-0.35]). For CT < 25, sensitivity was 100 % (95%CI [47.8-100.0]), specificity 99.6 % (95%CI [98.7-99.9]); PPV 94.4 % (95%CI [51.7-100]), NPV 100 % (95%CI [99.3-100]) and kappa = 0.83 (95%CI [0.6-1.0]). COVID-19 sequences generated were all Omicron BA.1 subvariants.

Conclusion:

For patients infected with high viral loads (CT < 25), INDICAID™ Ag-RDT has high intrinsic (sensitivity and specificity) and extrinsic (predictive values) performances for COVID-19 diagnosis. Due to its simplicity and short turnaround time, INDICAID™ Ag-RDT is, therefore a reliable tool to prevent the spread of COVID-19 at community level in the current era of Omicron subvariants.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Camarões

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Camarões